IOWA ONCOLOGY RESEARCH ASSOCIATION
Balance Sheet
Fiscal Year Start:
Aug 1
Assets in 2025 (Year End)
$398,855
Cash & Equivalents
55%
Receivables (Non-Related)
24%
Property, Plant, & Equipment (net)
19%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$85,246
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$329,297
$218,269
-34%
Receivables (Non-Related)
$1,268
$95,813
+7456%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$5,366
$9,319
+74%
Investments
-
-
-
Property, Plant, & Equipment (net)
$97,717
$75,454
-23%
Other Assets
-
-
-
Total Assets
$433,648
$398,855
-8%
Liabilities
2024
2025
Change
Payables & Accruals
$43,973
$85,246
+94%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$43,973
$85,246
+94%
Net assets
2024
2025
Change
Restricted Net Assets
-
$26,948
-
Unrestricted Net Assets
$389,675
$286,661
-26%
Net assets
2024
2025
Change
Net assets
+$389,675
+$313,609
-20%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)